Advertisement

General Thinking About Inflammation

  • Yoshiro Maru
Chapter

Abstract

Currently, the definition of “inflammation” is ambiguous. In ancient medicine, a tumor may be distinguished between inflammatory or neoplastic from the pathological standpoint. When you look at recent scientific literatures, even if the title contains the word “inflammation,” the actual story of the paper is the gene expression analysis of a group of chemokines. This means that “chemokine” is just representing a concept: “inflammation.” Originally, chemokines are growth factors that can stimulate leukocyte mobilization. We currently understand that most of the vascular permeability factors have the chemokine feature at the same time. I believe and therefore propose that it can be safely said that leukocyte mobilization and/or vasopermeability is necessary and sufficient for inflammation. Chapter  1 focuses on this issue.

Keywords

Chronic Myeloid Leukemia Haemophilus Influenzae Inflammatory Phase Acute Tonsillitis Cholesterol Ester Hydrolase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Retief FP, Cilliers L. Tumors and cancers in Graeco-Roman times. S Afr Med J. 2001;91:344–8.PubMedGoogle Scholar
  2. 2.
    Hippocrates. Epidemics I. Loeb class libr, vol. I. London: William Heinemann LTD; 1972. p. 150–5Google Scholar
  3. 3.
    Mcneil PL, Terasaki M. Coping with the inevitable: how cells repair a torn surface membrane. Nat Cell Biol. 2001;3:E124–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Xu S, Chisholm AD. A Galphaq-Ca(2)(+) signaling pathway promotes actin-mediated epidermal wound closure in C. elegans. Curr Biol. 2011;21:1960–7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Harris ES, Weyrich AS, Zimmerman GA. Lessons from rare maladies: leukocyte adhesion deficiency syndromes. Curr Opin Hematol. 2013;20:16–25.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Peters T, Sindrilaru A, Hinz B, et al. Wound-healing defect of CD18(−/−) mice due to a decrease in TGF-β1 and myofibroblast differentiation. EMBO J. 2005;24:3400–10.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Hori K, Ding J, Marcoux Y, et al. Impaired cutaneous wound healing in transforming growth factor-beta inducible early gene1 knockout mice. Wound Repair Regen. 2012;20:166–77.CrossRefPubMedGoogle Scholar
  8. 8.
    Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res. 2010;107:1170–84.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Banas M, Zabieglo K, Kasetty G, et al. Chemerin is an antimicrobial agent in human epidermis. PLoS One. 2013;8:e58709.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Cash JL, Bass MD, Campbell J, et al. Resolution mediator chemerin15 reprograms the wound microenvironment to promote repair and reduce scarring. Curr Biol. 2014;24:1406–14.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Roviezzo F, Getting SJ, Paul-Clark MJ, et al. The annexin-1 knockout mouse: what it tells us about the inflammatory response. J Physiol Pharmacol. 2002;53:541–53.PubMedGoogle Scholar
  12. 12.
    Zhang Q, Yamaza T, Kelly AP, et al. Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis. PLoS One. 2009;4:e7798.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Agrawal A, Singh PP, Bottazzi B, et al. Pattern recognition by pentraxins. Adv Exp Med Biol. 2009;653:98–116.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    De Beer MC, Webb NR, Wroblewski JM, et al. Impact of serum amyloid A on high density lipoprotein composition and levels. J Lipid Res. 2010;51:3117–25.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Japan 2016

Authors and Affiliations

  • Yoshiro Maru
    • 1
  1. 1.Department of PharmacologyTokyo Women’s Medical UniversityTokyoJapan

Personalised recommendations